SCHEMBL391334

SCHEMBL391334

COC(=O)c1cc([N+](=O)[O-])ccc1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.62
MAPT P10636 2/20 0.60
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
NPC1 O15118 1/20 0.60
HSP90AA1 P07900 1/20 0.60
PKM P14618 1/20 0.60
PAX8 Q06710 1/20 0.60
NPSR1 Q6W5P4 1/20 0.60
CA12 O43570 1/20 0.59
CA1 P00915 1/20 0.59
CA2 P00918 1/20 0.59
CA7 P43166 1/20 0.59
CA9 Q16790 1/20 0.59
CA14 Q9ULX7 1/20 0.59
ALDH1A1 P00352 3/20 0.53
TSHR P16473 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
TP53 P04637 1/20 0.51
HPGD P15428 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29448257 1.00 L3MBTL1 (0.62) L3MBTL1MAPTMEN1KMT2ANPC1
SCHEMBL19117 0.87 GAA (0.60) L3MBTL1MAPTMEN1KMT2ANPC1
SCHEMBL30203403 0.86 ALDH1A1 (0.56) L3MBTL1MAPTMEN1KMT2ANPC1
SCHEMBL1403472 0.86 ALDH1A1 (0.56) L3MBTL1MAPTMEN1KMT2ANPC1
SCHEMBL9068677 0.85 ALDH1A1 (0.54) L3MBTL1MAPTMEN1KMT2ANPC1
Methane SCHEMBL27588822 0.85 ALDH1A1 (0.54) L3MBTL1MAPTMEN1KMT2ANPC1
SCHEMBL1319532 0.83 ALDH1A1 (0.55) MAPTMEN1KMT2AALDH1A1TSHR
SCHEMBL13858435 0.83 ALDH1A1 (0.53) L3MBTL1MAPTMEN1KMT2ANPC1
SCHEMBL890895 0.83 ALDH1A1 (0.57) MAPTMEN1KMT2AALDH1A1TSHR
SCHEMBL31656235 0.83 L3MBTL1 (0.57) L3MBTL1MAPTMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 276 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3946461-B1 XYLOGLUCAN-CONTAINING PRODRUGS AND METHODS OF MANUFACTURE AND USE THEREOF UNIV BRITISH COLUMBIA (CA) 2025-01-15 EP claimed
US-20220184220-A1 XYLOGLUCAN-CONTAINING PRODRUGS AND METHODS OF MANUFACTURE AND USE THEREOF THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2022-06-16 US claimed
EP-3946461-A1 XYLOGLUCAN-CONTAINING PRODRUGS AND METHODS OF MANUFACTURE AND USE THEREOF The University of British Columbia (CA) 2022-02-09 EP claimed
WO-2020198878-A1 XYLOGLUCAN-CONTAINING PRODRUGS AND METHODS OF MANUFACTURE AND USE THEREOF THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2020-10-08 WO claimed
CN-102531955-A Preparation method of olsalazine disodium and postprocessing method of methyl sulfonation reaction Zhejiang zhongyi pharmaceutical co ltd 2012-07-04 CN claimed
US-8101655-B2 Fluorescent dyes and complexes SMITH GERALD ARTHUR (GB) 2012-01-24 US claimed
CN-102173992-A Preparation method of nitrophenol compounds UNIV NANTONG 2011-09-07 CN claimed
US-20070238884-A1 Fluorescent Dyes and Complexes CAMBRIDGE ENTERPRISE LIMITED (GB) 2007-10-11 US claimed
EP-1740947-A2 FLUORESCENT DYES AND COMPLEXES CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) 2007-01-10 EP claimed
WO-2005098437-A2 FLUORESCENT DYES AND COMPLEXES CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LTD (GB) 2005-10-20 WO claimed
US-20260138969-A1 TRIAZOLE COMPOUND HAVING NOVEL RING STRUCTURE, METHOD FOR PREPARING SAME, AND USE THEREOF KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2026-05-21 US disclosed
CN-116478130-B N-hydroxyquinoline carboxamide compounds and uses thereof 深圳默元生物科技有限公司 2025-05-30 CN disclosed
WO-2025105279-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2025-05-22 WO disclosed
CN-119894878-A Aromatic amide derivative and preparation method and application thereof 浙江海正药业股份有限公司 2025-04-25 CN disclosed
CN-119731169-A Sodium channel regulator and application thereof 上海汇伦医药股份有限公司 2025-03-28 CN disclosed
US-4528367-A Method and intermediates for preparing high purity 3,3'-azo-bis-(6-hydroxy benzoic acid) PHARMACIA AB (SE) 1985-07-09 US disclosed
EP-0036636-B1 A METHOD AND INTERMEDIATES FOR PREPARING 3,3'-AZO-BIS-(6-HYDROXY BENZOIC ACID) PHARMACIA AB (SE) 1984-02-15 EP disclosed
EP-0036637-B1 USE OF 3,3'-AZO-BIS-(6-HYDROXY BENZOIC ACID) AS A DRUG AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME PHARMACIA AB (SE) 1983-10-19 EP disclosed
EP-0036636-A1 A method and intermediates for preparing 3,3'-azo-bis-(6-hydroxy benzoic acid) PHARMACIA AB (SE) 1981-09-30 EP disclosed
EP-0036637-A1 Use of 3,3'-azo-bis-(6-hydroxy benzoic acid) as a drug and pharmaceutical compositions containing the same PHARMACIA AB (SE) 1981-09-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070238884-A1 Fluorescent Dyes and Complexes F12, PYM1, ANXA6 L3MBTL1 1855/4885MAPT 3961/4885MEN1 3023/4885
US-20260138969-A1 TRIAZOLE COMPOUND HAVING NOVEL RING STRUCTURE, METHOD FOR PREPARING SAME, AND USE THEREOF CASP1, CASP3, BAD L3MBTL1 249/4885MAPT 361/4885MEN1 2749/4885
US-20220184220-A1 XYLOGLUCAN-CONTAINING PRODRUGS AND METHODS OF MANUFACTURE AND USE THEREOF SI, FUT6, GALE L3MBTL1 2813/4885MAPT 2952/4885MEN1 4710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.